Postoperative reduced dose of cisplatin concomitant with radiation therapy in high‐ risk head and neck squamous cell carcinoma

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Cancer

• Publication date

  2009-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/cncr.24252PMID 19280588
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Long‐Term Results of a Phase III Randomized Trial of Postoperative Radiotherapy With or Without Carboplatin in Patients With High‐Risk Head and Neck Cancer

  2008cited by this paper
• Randomized clinical trial of post-operative radiotherapy versus concomitant carboplatin and radiotherapy for head and neck cancers with lymph node involvement.

  2008cited by this paper
• Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck.

  2004cited by this paper
• Postoperative chemoradiotherapy for high-risk head-and-neck squamous cell carcinoma.

  2004influential reference
• Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer.

  2004cited by this paper
• Common toxicity criteria: version 2.0. an improved reference for grading the acute effects of cancer treatment: impact on radiotherapy.

  2000cited by this paper
• Postoperative radiotherapy with concurrent cisplatin appears to improve locoregional control of advanced, resectable head and neck cancers: RTOG 88-24.

  1997cited by this paper
• Histological Typing of Cancer and Precancer of the Oral Mucosa

  1997cited by this paper
• Chemotherapy as an adjunct to radiation in the treatment of squamous cell carcinoma of the head and neck: results of the Yale Mitomycin Randomized Trials.

  1997cited by this paper
• Combined postoperative radiotherapy and weekly cisplatin infusion for locally advanced head and neck carcinoma: final report of a randomized trial.

  1996cited by this paper
• Postoperative Radiotherapy in Locally Advanced Head and Neck Cancer

  1989cited by this paper

• Overview of radiotherapy for oral cavity cancer

  2022cites this paper
• Solid Tumours and Update on Modern Medical Oncology Interventions

  2022cites this paper
• Systematic review of postoperative therapy for resected squamous cell carcinoma of the head and neck: Executive summary of the American Radium Society appropriate use criteria

  2020cites this paper
• Chemotherapy for Oral Cancer.

  2018cites this paper
• Comparison of standard-dose 3-weekly cisplatin and low-dose weekly cisplatin for concurrent chemoradiation of patients with locally advanced head and neck squamous cell cancer

  2018cites this paper
• Comparisons of the clinical outcomes of different postoperative radiation strategies for treatment of head and neck squamous cell carcinoma

  2017cites this paper
• A Study of Adjuvant Chemoradiotherapy with Tri-weekly Cisplatin for Postoperative High-risk Oral Squamous Cell Carcinoma.

  2017cites this paper
• Improved overall survival and mortality in head and neck cancer with adjuvant concurrent chemoradiotherapy in national databases

  2016cites this paper
• A comparison of weekly versus 3-weekly cisplatin during adjuvant radiotherapy for high-risk head and neck cancer.

  2016cites this paper
• A study of postoperative concurrent chemoradiotherapy with 3-weekly cycle of cisplatin for patients with high-risk squamous cell carcinoma of the head and neck

  2014cites this paper
• A study of adjuvant chemoradiotherapy with tri-weekly cisplatin for post-operative high-risk squamous cell carcinoma of oral cavity

  2013cites this paper
• Phase II feasibility trial of adjuvant chemoradiotherapy with 3-weekly cisplatin for Japanese patients with post-operative high-risk squamous cell carcinoma of the head and neck.

  2012cites this paper
• Concomitant adjuvant chemoradiotherapy with weekly low-dose cisplatin for high-risk squamous cell carcinoma of the head and neck: a phase II prospective trial.

  2011cites this paper
• Concomitant Adjuvant Chemoradiotherapy with Weekly Low-dose Cisplatin for High-risk Squamous Cell Carcinoma of the Head and Neck: a Phase II Prospective Trial

  year unknowncites this paper